{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:13:50Z","timestamp":1793247230943,"version":"4.5.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jconrel.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T18:25:18Z","timestamp":1663611918000},"page":"22-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":288,"special_numbering":"C","title":["Stealth nanoparticles in oncology: Facing the PEG dilemma"],"prefix":"10.1016","volume":"351","author":[{"given":"Sara","family":"Zalba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo L.M.","family":"ten Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Burgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.09.002_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2014.00069","article-title":"Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments","volume":"2","author":"Dawidczyk","year":"2014","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/nnm.11.79","article-title":"In vivo biodistribution of nanoparticles","volume":"6","author":"Almeida","year":"2011","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0040","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.nano.2017.02.008","article-title":"Tumor accumulation of liposomal doxorubicin in three murine models: optimizing delivery efficiency","volume":"13","author":"Dawidczyk","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4155\/tde-2018-0035","article-title":"Long circulating liposomes: challenges and opportunities","volume":"9","author":"Deodhar","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2967\/jnumed.115.166173","article-title":"Investigation of factors determining the enhanced permeability and retention effect in subcutaneous xenografts","volume":"57","author":"Bolkestein","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0065","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0075","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0080","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-409X(95)00023-Z","article-title":"Chemistry of polyethylene glycol conjugates with biologically active molecules","volume":"16","author":"Zalipsky","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/bc00032a002","article-title":"Functionalized poly(ethylene glycols) for preparation of biologically relevant conjugates","volume":"6","author":"Zalipsky","year":"1995","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0095","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0100","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0110","series-title":"Alkylene Oxides Their Polymers","article-title":"Alkylene oxides and their polymers","author":"Bailey","year":"2020"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jps.2600721213","article-title":"Acrylic microspheres in vivo IX: blood elimination kinetics and organ distribution of microparticles with different surface characteristics","volume":"72","author":"Arturson","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2016.05.029","article-title":"The early days of PEG and PEGylation (1970s-1990s)","volume":"40","author":"Hoffman","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0125","article-title":"PEG-derivatized dual-functional nanomicelles for improved cancer therapy","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1389200219666171207120643","article-title":"Long circulating polymeric nanoparticles for gene\/drug delivery","volume":"19","author":"Hu","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1166\/jbn.2008.021","article-title":"PEGylation of nanocarrier drug delivery systems: state of the art","volume":"4","author":"Howard","year":"2008","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0589-7","article-title":"Structural basis of polyethylene glycol recognition by antibody","volume":"27","author":"Lee","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0155","first-page":"2025","article-title":"Phase separation of non-ionic surfactant solutions. a treatment of the micellar interaction and form","volume":"78","author":"Kjellander","year":"1982","journal-title":"J. Chem. Soc. Faraday Trans. 2 Mol. Chem. Phys."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0160","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/10601325.2011.596041","article-title":"Super molecular-polarization phenomenon of poly (ethylene glycol) in deionized water","volume":"48","author":"Duan","year":"2011","journal-title":"J. Macromol. Sci. Part A Pure Appl. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0165","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S46900","article-title":"Nanopharmaceuticals (part 1): products on the market","volume":"9","author":"Weissig","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2022.09.002_bb0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"23","author":"Milton Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0175","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0180","first-page":"1719","article-title":"oncotargets and therapy dovepress a tale of the two PeGylated liposomal doxorubicins Dear editor","volume":"8","author":"Chou","year":"2015","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0185","doi-asserted-by":"crossref","first-page":"24699","DOI":"10.1039\/C9RA04358F","article-title":"Clinical developments of antitumor polymer therapeutics","volume":"9","author":"Parveen","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0190","first-page":"221","article-title":"Nanotechnology toward treating cancer: a comprehensive review","author":"Pillai","year":"2019","journal-title":"Appl. Target. Nano Drugs Deliv. Syst. Nanosci. Nanotechnol. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamaoncol.2022.0514","article-title":"Treatment with etirinotecan pegol for patients with metastatic breast cancer and brain metastases: final results from the phase 3 ATTAIN randomized clinical trial","volume":"8","author":"Tripathy","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0200","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0205","first-page":"3309","article-title":"Application of liposomal technologies for delivery of platinum analogs in oncology","volume":"8","author":"Liu","year":"2013","journal-title":"Int. J. Nanomed. Dovepress."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/125192","article-title":"Lipoplatin treatment in lung and breast cancer","volume":"2011","author":"Fantini","year":"2011","journal-title":"Chemother. Res. Pract."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0215","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1134\/S1068162018060031","article-title":"Platinum-based antitumor drugs and their liposomal formulations in clinical trials 1","volume":"44","author":"Arantseva","year":"2018","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0220","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0225","first-page":"541","article-title":"Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer","volume":"30","author":"Seetharamu","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0230","unstructured":"Phase I\/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01861496 (accessed August 10, 2022)."},{"issue":"91","key":"10.1016\/j.jconrel.2022.09.002_bb0235","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","article-title":"Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin","volume":"9110","author":"Matsumura","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u201cStealth\u201d corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0245","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0250","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/nn305663e","article-title":"A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes","volume":"7","author":"Stefanick","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0255","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1023\/A:1016091314940","article-title":"Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery","volume":"13","author":"Bedu-Addo","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0260","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.biomaterials.2008.12.026","article-title":"Stimuli-responsive interfaces and systems for the control of protein-surface and cell-surface interactions","volume":"30","author":"Cole","year":"2009","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0265","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1021\/nn301630n","article-title":"The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging","volume":"6","author":"Hak","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0280","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/nl302638g","article-title":"PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics","volume":"12","author":"Perry","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0285","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/acs.biomac.6b00146","article-title":"Adsorption of plasma proteins onto PEGylated lipid bilayers: the effect of PEG size and grafting density","volume":"17","author":"Lee","year":"2016","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0295","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbamem.2006.12.013","article-title":"Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding","volume":"1768","author":"Dos Santos","year":"2007","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0300","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1016\/S0006-3495(03)74798-5","article-title":"Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids","volume":"85","author":"Johnsson","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2018.02.015","article-title":"Immunoliposomes in clinical oncology: state of the art and future perspectives","volume":"275","author":"Merino","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2018.06.008","article-title":"Pharmacokinetics variability: why nanoparticles are not just magic-bullets in oncology","volume":"129","author":"Rodallec","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0320","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2217\/nnm-2018-0040","article-title":"Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application","volume":"13","author":"Wei","year":"2018","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0325","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/08982104.2016.1158185","article-title":"A lyophilized sterically stabilized liposome-containing docetaxel: in vitro and in vivo evaluation","volume":"27","author":"Chen","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0335","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0340","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0345","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00280-004-0825-y","article-title":"Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study","volume":"54","author":"Mross","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5507\/bp.2019.010","article-title":"Nanodrugs used in cancer therapy","volume":"163","author":"Kopeckova","year":"2019","journal-title":"Biomed. Pap."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0355","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semcancer.2019.08.028","article-title":"Implications of nanotechnology for the treatment of cancer: recent advances","volume":"69","author":"Klochkov","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0360","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/jps.20875","article-title":"Role of nanotechnology in pharmaceutical product development","volume":"96","author":"Devalapally","year":"2007","journal-title":"J. Pharm. Sci."},{"issue":"Suppl. 4","key":"10.1016\/j.jconrel.2022.09.002_bb0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-199700544-00005","article-title":"Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours","volume":"54","author":"Gabizon","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","article-title":"Pharmacokinetics of stealth versus conventional liposomes: effect of dose","volume":"1068","author":"Allen","year":"1991","journal-title":"BBA Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.03.022","article-title":"Characterization of pegylated and non-pegylated liposomal formulation for the delivery of hypoxia activated vinblastine-N-oxide for the treatment of solid tumors","volume":"253","author":"Shah","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0380","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0390","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0395","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1248\/bpb.b14-00653","article-title":"Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice","volume":"38","author":"Hashimoto","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0400","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/ml500112u","article-title":"Factors influencing in vivo disposition of polymeric micelles on multiple administrations","volume":"5","author":"Hara","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0405","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","article-title":"Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review","volume":"85","author":"Kanamala","year":"2016","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0410","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Abu Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0415","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1021\/bm100754e","article-title":"Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers","volume":"11","author":"Ishihara","year":"2010","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0420","first-page":"44","article-title":"The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin","volume":"13","author":"Su","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0425","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.biomaterials.2010.02.049","article-title":"Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0430","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2010.12.013","article-title":"Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA","volume":"151","author":"Tagami","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0435","first-page":"189","article-title":"The protein corona of circulating PEGylated liposomes","volume":"2016","author":"Palchetti","year":"1858","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0440","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tibtech.2016.08.011","article-title":"Biological identity of nanoparticles in vivo: clinical implications of the protein corona","volume":"35","author":"Caracciolo","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0445","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle-protein corona using methods to quntify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.05.042","article-title":"The hard protein corona of stealth liposomes is sparse","volume":"307","author":"Kristensen","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0455","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0460","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acs.biomac.5b00108","article-title":"Protein corona of nanoparticles: distinct proteins regulate the cellular uptake","volume":"16","author":"Ritz","year":"2015","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0465","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2004.07.028","article-title":"Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles","volume":"100","author":"Ogawara","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0470","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1021\/acsnano.5b01326","article-title":"Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake","volume":"9","author":"Pelaz","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0475","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(01)00399-6","article-title":"Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes","volume":"1558","author":"Song","year":"2002","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0485","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jconrel.2004.02.019","article-title":"The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes","volume":"97","author":"Deshpande","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0495","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1039\/C7NR09011K","article-title":"Aggregation of polyethylene glycol polymers suppresses receptor-mediated endocytosis of PEGylated liposomes","volume":"10","author":"Shen","year":"2018","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0500","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/jphp.13147","article-title":"Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin","volume":"71","author":"Samkange","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0505","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0510","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.colsurfb.2017.07.085","article-title":"Immunoliposomes: a review on functionalization strategies and targets for drug delivery","volume":"159","author":"Eloy","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0515","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","article-title":"Targeted anticancer therapy: overexpressed receptors and nanotechnology","volume":"436","author":"Akhtar","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0520","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The endosomal escape of nanoparticles: toward more efficient cellular delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1452","article-title":"Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles","volume":"9","author":"Selby","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118628","article-title":"Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry","volume":"569","author":"Gheibi Hayat","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0535","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(95)00138-S","article-title":"Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures","volume":"1239","author":"Hansen","year":"1995","journal-title":"BBA Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0540","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/IJN.S190736","article-title":"Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response","volume":"14","author":"Saeed","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0545","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-00846-z","article-title":"Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model","volume":"19","author":"Merino","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0550","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm.15.208","article-title":"EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model","volume":"11","author":"Zalba","year":"2016","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0555","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(99)00002-2","article-title":"Targetability of novel immunoliposomes prepared by a new antibody conjugation technique","volume":"181","author":"Bendas","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0560","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbamem.2007.09.033","article-title":"Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery","volume":"1778","author":"Bakowsky","year":"2008","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0565","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2006.12.007","article-title":"Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity","volume":"336","author":"Pan","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0570","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/bc060174r","article-title":"Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR","volume":"18","author":"Pan","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0575","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s11671-020-03334-9","article-title":"Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: in vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma","volume":"15","author":"Mashreghi","year":"2020","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0580","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fbioe.2022.847901","article-title":"Dacarbazine-loaded targeted polymeric nanoparticles for enhancing malignant melanoma therapy","volume":"10","author":"Xiong","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0585","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/ijms23042324","article-title":"Targeted delivery of cisplatin by gold nanoparticles: the influence of nanocarrier surface modification type on the efficiency of drug binding examined by CE-ICP-MS\/MS","volume":"23","author":"Wr\u00f3blewska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0590","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/ijms23031200","article-title":"Antibody conjugated PLGA nanocarriers and superparmagnetic nanoparticles for targeted delivery of oxaliplatin to cells from colorectal carcinoma","volume":"23","author":"Zumaya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0595","first-page":"7190","article-title":"Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs","volume":"62","author":"Sapra","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0600","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2147\/DDDT.S132841","article-title":"Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomes","volume":"11","author":"Guo","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0605","doi-asserted-by":"crossref","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0610","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1166\/jnn.2014.9082","article-title":"Endosomal escape: a bottleneck in intracellular delivery","volume":"14","author":"Shete","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0615","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2013.08.034","article-title":"Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro\/in vivo live cell imaging","volume":"172","author":"Seynhaeve","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0620","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0625","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2006.10.029","article-title":"Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides","volume":"117","author":"Remaut","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0630","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/bc000110v","article-title":"Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG - Diortho ester - lipid conjugate","volume":"12","author":"Guo","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbamem.2003.10.011","article-title":"Characterization and transfection properties of lipoplexes stabilized with novel exchangeable polyethylene glycol-lipid conjugates","volume":"1660","author":"Rejman","year":"2004","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0640","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1039\/C9BM01927H","article-title":"Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/smll.201903296","article-title":"pH-Responsive PEG-shedding and targeting peptide-modified nanoparticles for dual-delivery of irinotecan and microRNA to enhance tumor-specific therapy","volume":"15","author":"Juang","year":"2019","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0650","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2017.07.046","article-title":"pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes","volume":"262","author":"Hashiba","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0655","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2217\/nnm-2018-0510","article-title":"Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery","volume":"14","author":"Kanamala","year":"2019","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0660","first-page":"6199","article-title":"An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery","volume":"10","author":"Ding","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0665","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acs.biomac.7b00080","article-title":"A pH-responsive detachable PEG shielding strategy for gene delivery system in cancer therapy","volume":"18","author":"Guan","year":"2017","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0670","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.apsb.2018.11.006","article-title":"Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy","volume":"9","author":"Zhong","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0675","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1073\/pnas.1304987110","article-title":"Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0680","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/1061186X.2013.875029","article-title":"Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery","volume":"22","author":"Tang","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0685","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.biomaterials.2011.02.045","article-title":"Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid","volume":"32","author":"Hatakeyama","year":"2011","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0690","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.apsb.2013.12.004","article-title":"A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomes","volume":"4","author":"Tang","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0695","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.actbio.2018.09.040","article-title":"Programmed pH\/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo","volume":"81","author":"Chen","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0700","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1016\/j.biomaterials.2014.05.050","article-title":"Matrix metalloproteinase 2-responsive micelle for siRNA delivery","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0705","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2018.04.015","article-title":"Photoinduced PEG deshielding from ROS-sensitive linkage-bridged block copolymer-based nanocarriers for on-demand drug delivery","volume":"170","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0710","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/acs.bioconjchem.6b00355","article-title":"Shedding PEG palisade by temporal photostimulation and intracellular reducing milieu for facilitated intracellular trafficking and DNA release","volume":"27","author":"Wang","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0715","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2016.02.031","article-title":"Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery","volume":"88","author":"Xu","year":"2016","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0720","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.msec.2017.08.079","article-title":"Stepwise pH\/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor","volume":"82","author":"Yang","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0725","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0730","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0735","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/nn300524f","article-title":"Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting","volume":"6","author":"Zhu","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0740","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-5793(96)00521-2","article-title":"Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol)","volume":"388","author":"Kirpotin","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0745","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.phrs.2003.09.003","article-title":"Pharmaco attributes of dioleoylphosphatidylethanolamine\/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers","volume":"49","author":"Zhang","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0750","series-title":"Liposome Technol","first-page":"139","article-title":"Synthesis and advantages of acid-labile formulations for lipoplexes","volume":"1","author":"Garinot","year":"2006"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0755","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/bc060080h","article-title":"\u201cSMART\u201d drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers","volume":"17","author":"Sawant","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0760","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ymthe.2004.11.006","article-title":"Toward synthetic viruses: endosomal pH-Triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo","volume":"11","author":"Walker","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0765","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/bc060228x","article-title":"Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the pH stability of PEG-PE conjugates","volume":"18","author":"Kale","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0770","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2004.07.016","article-title":"pH-Sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery","volume":"99","author":"Masson","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0775","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1021\/ja00456a051","article-title":"Ortho ester hydrolysis.the complete reaction mechanism","volume":"99","author":"Ahmad","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0780","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(03)00232-3","article-title":"Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids, in","author":"Shin","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0785","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0301-4622(03)00011-5","article-title":"Interactions between pH-sensitive liposomes and model membranes","volume":"104","author":"Bergstrand","year":"2003","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0790","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/acs.nanolett.6b05396","article-title":"Tumor acidity\/NIR controlled interaction of transformable nanoparticle with biological systems for cancer therapy","volume":"17","author":"Li","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0795","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.colsurfb.2006.02.006","article-title":"A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating","volume":"49","author":"Maeda","year":"2006","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0800","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.gt.3301227","article-title":"Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery","volume":"7","author":"Finsinger","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0805","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.biomaterials.2005.08.036","article-title":"PH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes","volume":"27","author":"Auguste","year":"2006","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0810","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/bm0503571","article-title":"pH-Responsive sulfonamide, PEI system for tumor specific gene delivery: an in vitro study","volume":"7","author":"Sethuraman","year":"2006","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0815","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(02)46046-6","article-title":"Gene therapy for hypertension: the preclinical data","volume":"346","author":"Phillips","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0820","doi-asserted-by":"crossref","first-page":"1700375","DOI":"10.1002\/smtd.201700375","article-title":"State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery","volume":"2","author":"Evers","year":"2018","journal-title":"Small Meth."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0825","article-title":"RNA interference by single- and double-stranded siRNA with a DNA extension containing a 3\u2032 nuclease-resistant mini-hairpin structure","volume":"2","author":"Allison","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0830","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/bj20020590","article-title":"Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions","volume":"366","author":"Shi","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0835","first-page":"208","article-title":"Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells","volume":"121","author":"Peeters","year":"2007"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0840","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0845","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/nnm-2019-0388","article-title":"Cell membrane-coated nanoparticles: research advances","volume":"15","author":"Zou","year":"2020","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0850","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.bioconjchem.6b00569","article-title":"Biointerfacing and applications of cell membrane-coated nanoparticles","volume":"28","author":"Kroll","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0855","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.2147\/IJN.S200284","article-title":"Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy","volume":"14","author":"Wu","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0860","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/polym10090983","article-title":"Cell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics","volume":"10","author":"Vijayan","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0865","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","article-title":"Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy","volume":"327","author":"Dash","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0870","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1073\/pnas.85.18.6949","article-title":"Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors","volume":"85","author":"Gabizon","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0875","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0880","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/adma.201300638","article-title":"Surface functionalization of gold nanoparticles with red blood cell membranes","volume":"25","author":"Gao","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0885","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0890","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0895","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0900","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1021\/acs.nanolett.5b04237","article-title":"Nanoghosts as a novel natural nonviral gene delivery platform safely targeting multiple cancers","volume":"16","author":"Kaneti","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0905","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1158\/0008-5472.CAN-17-1547","article-title":"Therapy-educated mesenchymal stem cells enrich for tumor-initiating cells","volume":"78","author":"Timaner","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0910","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/acsnano.8b07241","article-title":"Biomimetic glyconanoparticle vaccine for cancer immunotherapy","volume":"13","author":"Reuven","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0915","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/10717544.2020.1745326","article-title":"Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors","volume":"27","author":"Kuo","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0920","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/bc00030a001","article-title":"New amphipatic polymer\u2014lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes","volume":"5","author":"Woodle","year":"1994","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0925","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jps.23823","article-title":"Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery","volume":"103","author":"Abu Lila","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0930","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1021\/acsnano.0c02289","article-title":"Polyglycerol grafting shields nanoparticles from protein corona formation to avoid macrophage uptake","volume":"14","author":"Zou","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0935","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.biomac.9b00539","article-title":"Functionalization of liposomes with hydrophilic polymers results in macrophage uptake independent of the protein corona","volume":"20","author":"Weber","year":"2019","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0940","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1248\/bpb.24.795","article-title":"Passive targeting of doxorubicin with polymer coated liposomes in tumor bearing rats","volume":"24","author":"Takeuchi","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0945","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0005-2736(94)90025-6","article-title":"Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo","volume":"1195","author":"Torchilin","year":"1994","journal-title":"BBA Biomembr."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0950","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/S0142-9612(01)00050-3","article-title":"Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification","volume":"22","author":"Torchilin","year":"2001","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0955","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.2174\/0929867325666180601101859","article-title":"Coating matters: review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms","volume":"25","author":"Schubert","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0960","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1081\/LPR-100108459","article-title":"Poly(HPMA)-coated liposomes demonstrate prolonged circulation in mice","volume":"11","author":"Whiteman","year":"2001","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0970","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2017.01.040","article-title":"Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity","volume":"250","author":"Mima","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0975","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/bc0340363","article-title":"A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity","volume":"14","author":"Metselaar","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0980","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/bm901123j","article-title":"Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: toward multifunctional stealth liposomes","volume":"11","author":"Hofmann","year":"2010","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0985","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biotechadv.2010.10.003","article-title":"A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides","volume":"29","author":"Dias","year":"2011","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb0990","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2020.03.022","article-title":"Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes","volume":"322","author":"Son","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.09.002_bb0995","doi-asserted-by":"crossref","first-page":"1904716","DOI":"10.1002\/smll.201904716","article-title":"Poly(sarcosine) surface modification imparts stealth-like properties to liposomes","volume":"15","author":"Bleher","year":"2019","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1000","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcis.2016.08.038","article-title":"Gold nanoparticles coated with polysarcosine brushes to enhance their colloidal stability and circulation time in vivo","volume":"483","author":"Chen","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1005","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1002\/adma.201202296","article-title":"Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor","volume":"24","author":"Yuan","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1010","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1021\/acs.langmuir.9b00013","article-title":"Zwitterionic polydopamine-coated manganese oxide nanoparticles with ultrahigh longitudinal relaxivity for tumor-targeted MR imaging","volume":"35","author":"Wang","year":"2019","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1015","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1021\/acs.biomac.0c00497","article-title":"Interactions between biomolecules and zwitterionic moieties: a review","volume":"21","author":"Erfani","year":"2020","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/adma.200901407","article-title":"Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications","volume":"22","author":"Jiang","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1025","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/la500057j","article-title":"Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption","volume":"30","author":"Schlenoff","year":"2014","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1030","doi-asserted-by":"crossref","first-page":"eaaw9562","DOI":"10.1126\/sciadv.aaw9562","article-title":"Trimethylamine N-oxide\u2013derived zwitterionic polymers: a new class of ultralow fouling bioinspired materials","volume":"5","author":"Li","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nantod.2014.02.004","article-title":"Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production","volume":"9","author":"Yang","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2022.09.002_bb1040","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1021\/ja1005493","article-title":"Small and stable sulfobetaine zwitterionic quantum dots for functional live-cell imaging","volume":"132","author":"Muro","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/nn203892h","article-title":"Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry","volume":"6","author":"Wang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.002_bb1050","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1021\/ja400701c","article-title":"Charged gold nanoparticles with essentially zero serum protein adsorption in undiluted fetal bovine serum","volume":"135","author":"Murthy","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1055","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1039\/b915125g","article-title":"Zwitterionic phosphorylcholine as a better ligand for gold nanorods cell uptake and selective photothermal ablation of cancer cells","volume":"46","author":"Zhou","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1060","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1021\/la201940r","article-title":"Surface functionalization of silica nanoparticles with cysteine: a low-fouling zwitterionic surface","volume":"27","author":"Rosen","year":"2011","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1065","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/la302433a","article-title":"Superhydrophilic zwitterionic polymers stabilize liposomes","volume":"28","author":"Cao","year":"2012","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2022.09.002_bb1070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","article-title":"Micelles with ultralow critical micelle concentration as carriers for drug delivery","volume":"2","author":"Lu","year":"2018","journal-title":"Nat. Biomed. Eng."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:24:05Z","timestamp":1759163045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":214,"alternative-id":["S0168365922005867"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stealth nanoparticles in oncology: Facing the PEG dilemma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}